The objective of this study was to identify the pharmacological effects of bee venom and its major component, melittin, on the nervous system of mice. For the pharmacological analysis, mice were treated once with saline, 0.1 or 1.2 mg/kg of bee venom and 0.1 mg/kg of melittin, subcutaneously, 30 min before being submitted to behavioral tests: locomotor activity and grooming (open-field), catalepsy, anxiety (elevated plus-maze), depression (forced swimming test) and apomorphine-induced stereotypy. Haloperidol, imipramine and diazepam were administered alone (positive control) or as a pre-treatment (haloperidol).The bee venom reduced motor activity and promoted cataleptic effect, in a similar manner to haloperidol.These effects were decreased by the pretreatment with haloperidol. Both melittin and bee venom decreased the apomorphine-induced stereotypies. The data indicated the antipsychotic activity of bee venom and melittin in a murine model.

A sulfated polysaccharide (SPSG) was successfully isolated from seagrass Halodule wrightii Asch., Cymodoceaceae, and its antioxidant and anticoagulant activities were investigated. The data presented here showed that the SPSG is a 11 kDa sulfated heterogalactan with a sulfatation degree of 20.63% and it also contains glucose and xylose. SPSG antioxidant activities were evaluated using several in vitro assays and the anticoagulant activity was evaluated by aPTT and PT tests. These assays suggested that the SPSG possessed remarkable antioxidant properties in different in vitro assays and an outstanding anticoagulant activity 2.5-fold higher than that of heparin Clexane® in the aPTT test. This data represents the first reported on the sulfated polysaccharide biological activities from seagrass. These results indicate that SPSG can be considered in the future as a drug utilized in treating diseases from these systems.

OBJETIVO: Avaliar a concentração de alfa-tocoferol no soro e colostro maternos, seja em condições de jejum ou pós-prandial. MÉTODOS: Trinta parturientes saudáveis atendidas em uma maternidade pública foram recrutadas para o estudo, e amostras de sangue, colostro em jejum e colostro pós-prandial foram coletadas até 12 horas pós-parto. RESULTADOS: A concentração sérica de alfa-tocoferol foi de 1.939,8±766,0 μg/dL. O alfa-tocoferol no colostro em jejum, 1.603,4±911,0 μg/dL, e após a refeição, 1.515,0±890,9 μg/dL, não apresentaram diferença significativa (p > 0,05). Houve correlação entre o alfa-tocoferol do colostro na condição de jejum e no pós-prandial (p < 0,05), mas não entre o soro e o colostro. CONCLUSÃO: A falta de correlação entre o alfa-tocoferol no plasma e no colostro e a correlação entre o alfa-tocoferol no colostro em jejum e no pós-prandial reforçam a hipótese de um mecanismo de controle na passagem desse micronutriente, independente do aporte dietético.

OBJECTIVE: To evaluate alpha-tocopherol concentrations in maternal serum and colostrum under fasting and postprandial conditions. METHODS: Thirty healthy childbearing women were recruited in a public maternity hospital, and samples of blood, fasting colostrum, and postprandial colostrum were collected from them up to 12 hours after delivery. RESULTS: The serum alpha-tocopherol concentration was 1,939.8±766.0 μg/dL. Alpha-tocopherol levels in fasting colostrum (1,603.4±911.0 μg/dL) and in postprandial colostrum (1,515.0±890.9 μg/dL) did not demonstrate a statistically significant difference (p > 0.05). There was correlation between alpha-tocopherol levels in fasting and postprandial colostrum (p < 0.05), but not between serum and colostrum. CONCLUSION: The lack of correlation between alpha-tocopherol levels in plasma and in colostrum, and the correlation between alpha-tocopherol concentrations in fasting and postprandial colostrum support the existence of a mechanism that controls the transfer of this nutrient, regardless of dietary intake.